Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-26-000174
Filing Date
2026-01-30
Accepted
2026-01-29 21:59:23
Documents
47
Period of Report
2023-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vsbc_10q.htm   iXBRL 10-Q 571327
2 CERTIFICATION vsbc_ex311.htm EX-31.1 10290
3 CERTIFICATION vsbc_ex321.htm EX-32.1 3811
  Complete submission text file 0001640334-26-000174.txt   2624659

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vsbc-20231031.xsd EX-101.SCH 23239
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsbc-20231031_lab.xml EX-101.LAB 164856
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsbc-20231031_cal.xml EX-101.CAL 32689
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsbc-20231031_pre.xml EX-101.PRE 124347
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsbc-20231031_def.xml EX-101.DEF 35431
50 EXTRACTED XBRL INSTANCE DOCUMENT vsbc_10q_htm.xml XML 336921
Mailing Address 5225 CANYON CREST DR. STE 71-825 RIVERSIDE CA 92507
Business Address 5225 CANYON CREST DR. STE 71-825 RIVERSIDE CA 92507 9492029235
VITASPRING BIOMEDICAL CO. LTD. (Filer) CIK: 0001697884 (see all company filings)

EIN.: 371836726 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-216465 | Film No.: 26580276
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)